Market Research Logo

Angina (Angina Pectoris) - Pipeline Review, H2 2018

Angina (Angina Pectoris) - Pipeline Review, H2 2018

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina (Angina Pectoris) - Pipeline Review, H2 2018, provides an overview of the An


Introduction
Global Markets Direct Report Coverage
Angina (Angina Pectoris) - Overview
Angina (Angina Pectoris) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Products under Development by Companies
Angina (Angina Pectoris) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Angina (Angina Pectoris) - Companies Involved in Therapeutics Development
Angionetics Inc
Caladrius Biosciences Inc
G. Pohl-Boskamp GmbH & Co KG
Hemostemix Inc
ID Pharma Co Ltd
Kuhnil Pharmaceutical Co Ltd
TSH Biopharm Corporation Ltd
ViroMed Co Ltd
XyloCor Therapeutics Inc
Angina (Angina Pectoris) - Drug Profiles
ACP-01 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
alferminogene tadenovec - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CLBS-14 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
CLBS-14RfA - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
donaperminogene seltoplasmid - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
DVC-10101 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EG-011 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
KI-1007 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
nitroglycerin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ranolazine ER - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Angina - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
XC-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Angina (Angina Pectoris) - Dormant Projects
Angina (Angina Pectoris) - Discontinued Products
Angina (Angina Pectoris) - Product Development Milestones
Featured News & Press Releases
Jul 18, 2018: Hemostemix announces first U.S. Patients treated in phase II clinical trial
Jun 19, 2018: Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina
May 08, 2017: FDA Grants Fast Track designation to XyloCor Therapeutics Lead Candidate XC001
Feb 07, 2017: FDA Grants Fast Track Designation To Angionetics' Generx Product Candidate, A One-Time Gene Therapy For Coronary Heart Disease
Sep 26, 2016: Espero Pharmaceuticals Announces the Availability of FDA-Approved GONITRO (Nitroglycerin) Sublingual Powder in the U.S.
Sep 12, 2016: Angionetics' Generx Gene Therapy Biologic Receives FDA Clearance For U.S. Phase 3 Clinical Study As A New, Single Dose, Treatment For Coronary Artery Disease
Aug 31, 2016: Espero Pharmaceuticals Selects DDB Health and Alamo Pharma Services as Partners for the Launch of GONITRO (Nitroglycerin) Sublingual Powder
Jun 14, 2016: Espero Pharmaceuticals Receives FDA Approval for GONITRO (Nitroglycerin) Sublingual Powder
May 11, 2015: Angionetics Presents At 2015 Annual Marcum MicroCap Conference On Business And Generx Clinical Development Activities
Jan 27, 2015: Taxus Cardium Announces Scientific Presentation And Clinical Update On Phase 3 Angiogenic Gene Therapy At The 2015 Phacilitate 11th Annual Cell & Gene Therapy Forum
Aug 13, 2014: Cardium Announces Review in Journal Of Cardiovascular Pharmacology Finds Gene Therapy For Subset Of Heart Disease Patients 'Highly Warranted'
May 02, 2013: Cardium Therapeutics Announces Publication Of Data On Generx In Journal Molecular Therapy
Nov 19, 2012: Cardium Therapeutics Announces Patent Award For Rights To Cardiovascular Gene Therapy For Treatment Of Heart Disease
May 16, 2012: Ark Completes Dose Ranging Phase I Section Of Refractory Angina Clinical Study
Jul 07, 2011: Phase Two Study Suggests Use Of Adult Autologous Stem Cells May Improve Cardiac Function In Angina Patients
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Number of Products under Development for Angina (Angina Pectoris), H2 2018
Number of Products under Development by Companies, H2 2018
Products under Development by Companies, H2 2018
Number of Products by Stage and Target, H2 2018
Number of Products by Stage and Mechanism of Action, H2 2018
Number of Products by Stage and Route of Administration, H2 2018
Number of Products by Stage and Molecule Type, H2 2018
Angina (Angina Pectoris) - Pipeline by Angionetics Inc, H2 2018
Angina (Angina Pectoris) - Pipeline by Caladrius Biosciences Inc, H2 2018
Angina (Angina Pectoris) - Pipeline by G. Pohl-Boskamp GmbH & Co KG, H2 2018
Angina (Angina Pectoris) - Pipeline by Hemostemix Inc, H2 2018
Angina (Angina Pectoris) - Pipeline by ID Pharma Co Ltd, H2 2018
Angina (Angina Pectoris) - Pipeline by Kuhnil Pharmaceutical Co Ltd, H2 2018
Angina (Angina Pectoris) - Pipeline by TSH Biopharm Corporation Ltd, H2 2018
Angina (Angina Pectoris) - Pipeline by ViroMed Co Ltd, H2 2018
Angina (Angina Pectoris) - Pipeline by XyloCor Therapeutics Inc, H2 2018
Angina (Angina Pectoris) - Dormant Projects, H2 2018
Angina (Angina Pectoris) - Dormant Projects, H2 2018 (Contd..1), H2 2018
Angina (Angina Pectoris) - Discontinued Products, H2 2018
List of Figures
Number of Products under Development for Angina (Angina Pectoris), H2 2018
Number of Products under Development by Companies, H2 2018
Number of Products by Targets, H2 2018
Number of Products by Stage and Targets, H2 2018
Number of Products by Mechanism of Actions, H2 2018
Number of Products by Stage and Mechanism of Actions, H2 2018
Number of Products by Routes of Administration, H2 2018
Number of Products by Stage and Routes of Administration, H2 2018
Number of Products by Molecule Types, H2 2018
Number of Products by Stage and Molecule Types, H2 2018

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report